Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(22%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
1
11%
Ph phase_2
1
11%
Ph not_applicable
7
78%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (11.1%)
Phase 31 (11.1%)
N/A7 (77.8%)

Trials by Status

recruiting222%
unknown333%
completed444%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9